Pathogenic NAP57 mutations decrease ribonucleoprotein assembly in dyskeratosis congenita.

Area of Science:

• Molecular Biology
• Genetics
• Biochemistry

Background:

• X-linked dyskeratosis congenita (DC) is a rare bone marrow failure disorder.
• It is primarily caused by mutations in the NAP57 (dyskerin/Cbf5) gene, a pseudouridine synthase.
• NAP57 is essential for the biogenesis of various ribonucleoprotein complexes (RNPs), including ribosomes, spliceosomes, microRNAs, and telomerase.

Purpose of the Study:

• To investigate the functional impact of DC-associated mutations in NAP57.
• To elucidate the role of NAP57's N- and C-termini in its interactions with the H/ACA RNP assembly factor SHQ1.
• To establish a molecular basis for X-linked DC by examining the NAP57-SHQ1 interaction.

Main Methods:

• Site-directed mutagenesis to create DC-associated NAP57 mutations.
• Biochemical assays to assess the interaction between NAP57 and SHQ1.
• Analysis of mutation effects on the NAP57-SHQ1 binding interface.

Main Results:

• Mutations causing X-linked DC cluster in the N- and C-termini of NAP57, not the catalytic domain.
• The N- and C-termini of NAP57 form a critical binding surface for the SHQ1 assembly factor.
• DC mutations were shown to modulate the binding affinity between NAP57 and SHQ1.

Conclusions:

• Impaired interaction between NAP57 and SHQ1 is a potential molecular mechanism underlying X-linked DC.
• Understanding this interaction provides a basis for developing targeted therapeutic strategies for X-linked DC.
• Small molecules targeting the NAP57-SHQ1 interface could offer novel treatment avenues.